期刊
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
卷 28, 期 1, 页码 70-74出版社
KARGER
DOI: 10.1159/000230877
关键词
Blood pressure; Alzheimer's disease; Longitudinal study
资金
- Charles Wolfson Charitable Trust,
- Alzheimer's Research Trust
- Merck Co Inc.
- Oxford Comprehensive Biomedical Research Centre funding from the Department of Health's NIHR Biomedical Research Centres funding scheme, UK
- Department of Health and Human Services, Tasmania, Australia
Background/Aims: Studies on the relation between blood pressure (BP), dementia and Alzheimer's disease (AD) have yielded inconsistent results, showing an association with high or low BP, or no association with BP. The study was designed to look at the longitudinal effect of BP on cognitive function. Methods: Participants were part of the OPTIMA longitudinal study of patients with dementia and age-matched cognitively healthy controls. The Cambridge Cognitive Examination (CAMCOG) and BP were measured. We tested the dependence of CAMCOG scores on BP using generalised linear mixed models. Results: A total of 235 were cognitively healthy controls, 42 had mild cognitive impairment (MCI), 141 had AD, and 59 had other dementia syndrome (ODS). In AD patients, the rate of decline of CAMCOG scores showed an inverted U-shaped (non-linear) dependence on diastolic BP. High (110 mm Hg) and low (60 mm Hg) levels of diastolic BP were related to faster cognitive decline over 5 years of follow-up (z = -2.51, p = 0.012). CAMCOG scores also showed an inverted U-shaped dependence on pulse pressure (z = -2.29, p = 0.022). Conclusion: High and low BP levels are related to faster cognitive decline in AD patients. This could have implications for the prevention and treatment of AD. Copyright (c) 2009 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据